GlassScriptPhysician profile
Lundon R Albrecht
NPI 1144531005
$77,232.18
in general payments reported to CMS, 2019-2025
6 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,022 · 2020: $4,094 · 2021: $111 · 2022: $15K · 2023: $21K · 2024: $13K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $46K · Travel and Lodging: $2,685 · Entertainment: $215 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $46,000.00 |
| Travel and Lodging | $2,685.19 |
| Entertainment | $214.70 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coltene Whaledent INC. | $75,266.34 | 2019-2025 | |
| Henry Schein, INC. | $1,500.00 | 2022 | |
| Align Technology, INC. | $185.20 | 2020-2021 | |
| Ultradent Products INC | $168.53 | 2022 | |
| Garrison Dental Solutions | $99.00 | 2024 | |
| Colgate Oral Pharmaceuticals, INC. | $13.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lundon Albrecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.